55N-44149-31723 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-29
Registered in v-safe
2020-12-29
Dose 1 — Pfizer-BioNTech
2020-12-29
Health check-in — day 0, dose 1
Feeling: Good · Muscle or body aches

Adult check-in
2020-12-30
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2020-12-31
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Joint pains, Fatigue or tiredness

Adult check-in
2021-01-01
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Joint pains, Fatigue or tiredness

Adult check-in
2021-01-02
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Fatigue or tiredness

Adult check-in
2021-01-03
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2021-01-04
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-08
Survey response — day 7, dose 1
MedDRA: Dyspnoea, Lacrimation increased, Nasal congestion, Rhinorrhoea — Feeling: Fair · Diarrhea, Abdominal pain

Free text: Running nose, and nasal congestion, watery eyes, short of breath

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-13
Survey response — day 14, dose 1
MedDRA: Dyspnoea, Nasal congestion, Rhinorrhoea, Wheezing — Feeling: Fair

Free text: Nasal congestion, and runny nose, wheezing and short of breath

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-19
Dose 2 — Pfizer-BioNTech
2021-01-28
Survey response — day 7, dose 2
MedDRA: Nasal congestion — Feeling: Good · Fatigue or tiredness

Free text: Nasal congestion

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-04
Survey response — day 14, dose 2
MedDRA: Arthralgia, Chills, Dizziness, Headache, Myalgia, Nausea, Vertigo — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities

Free text: Severe headache, nausea, chills, joint pain and muscle pain, dizzy, vertigo

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-09
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-16
Health check-in — day 28, dose 2
Feeling: Fair

Adult check-in
2021-02-23
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-03
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-26
Survey response — 3 months, dose 2
MedDRA: Aura, Blindness, Emergency care, Eye pain, Facial paralysis, Fatigue, Headache, Hypertension, Office visit — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization

Free text: Symptoms: Severe headaches, Daily visual aura headaches, one sided facial droop with migraine, unequal dilation of eye pupils, extreme eye sensitivity to light, vision loss changes, extreme high blood pressure, daily fatigue, feeling tired. · Healthcare visit (other): Several emergency room visits:CatScan, EKG, lab work, MRI, new medications, referrals specialist

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-26
Report sent to call center — 3 months, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-12-30
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-29	Pfizer-BioNTech
2	2021-01-19	Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 1 — day 7, dose 1

2021-01-08

Systemic reaction (other): Running nose, and nasal congestion, watery eyes, short of breath

Release 1 — day 14, dose 1

2021-01-13

Symptoms: Nasal congestion, and runny nose, wheezing and short of breath

Release 2 — day 7, dose 2

2021-01-28

Systemic reaction (other): Nasal congestion

Release 3 — day 14, dose 2

2021-02-04

Symptoms: Severe headache, nausea, chills, joint pain and muscle pain, dizzy, vertigo

Release 8 — 3 months, dose 2

2021-04-26

Symptoms: Severe headaches, Daily visual aura headaches, one sided facial droop with migraine, unequal dilation of eye pupils, extreme eye sensitivity to light, vision loss changes, extreme high blood pressure, daily fatigue, feeling tired.

Healthcare visit (other): Several emergency room visits:CatScan, EKG, lab work, MRI, new medications, referrals specialist

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Emergency care	✓	✓	✓
HCVO	Office visit	✓	✓	✓
SD	Arthralgia	✓	✓	✓
SD	Aura	✓	✓	✓
SD	Blindness	✓	✓	✓
SD	Chills	✓	✓	✓
SD	Dizziness	✓	✓	✓
SD	Dyspnoea	✓	✓	✓
SD	Eye pain	✓	✓	✓
SD	Facial paralysis	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Hypertension	✓	✓	✓
SD	Myalgia	✓	✓	✓
SD	Nasal congestion	✓	✓	✓
SD	Nausea	✓	✓	✓
SD	Rhinorrhoea	✓	✓	✓
SD	Vertigo	✓	✓	✓
SD	Wheezing	✓	✓	✓
SRO	Dyspnoea	✓	✓	✓
SRO	Lacrimation increased	✓	✓	✓
SRO	Nasal congestion	✓	✓	✓
SRO	Rhinorrhoea	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release